GB Patent

GB2262452A — Inhalation device

Assigned to 3M Co · Expires 1993-06-23 · 33y expired

What this patent protects

An inhalation device for administration of aerosolised medicament to the respiratory system of a patient, in which the inhalation device accommodates a reservoir of medicament which comprises information relating to the medicament and the inhalation device includes sensing means …

USPTO Abstract

An inhalation device for administration of aerosolised medicament to the respiratory system of a patient, in which the inhalation device accommodates a reservoir of medicament which comprises information relating to the medicament and the inhalation device includes sensing means capable of detecting said information and means to display or use the detected information. Suitable sensing means include electrical contacts which mate with corresponding coded electrical contacts in the form of wipers, spring loaded contacts or pins/sockets on the medicament reservoir in a similar manner to the DX-coding arrangement in cameras.

Drugs covered by this patent

Patent Metadata

Patent number
GB2262452A
Jurisdiction
GB
Classification
—
Expires
1993-06-23
Drug substance claim
No
Drug product claim
No
Assignee
3M Co
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.